Do IV Antibiotics Help PTLDS? What the Research Shows
Post-Treatment Lyme Disease Syndrome (PTLDS) continues to be one of the most debated topics in Lyme disease medicine.
Some patients improve after standard treatment, while others continue to experience fatigue, cognitive dysfunction, pain, or neurologic symptoms for months or years.
A recent systematic review and network meta-analysis evaluated whether antibiotic therapy—particularly intravenous ceftriaxone—may help some patients with persistent symptoms after Lyme disease. [1]
What the Meta-Analysis Reviewed
In the study “Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis”, Zhang and colleagues analyzed four randomized controlled trials involving 485 participants diagnosed with PTLDS. [1]
The studies included patients who:
- Had persistent symptoms lasting at least 6 months after initial Lyme disease treatment
- Tested positive by IgG Western blot
- Were 18 years of age or older
- Received either antibiotic therapy or placebo
The authors evaluated outcomes involving fatigue, cognition, physical functioning, and mental health measures.
IV Ceftriaxone Showed Improvement in Fatigue Scores
The meta-analysis found that intravenous ceftriaxone performed better than placebo on the Fatigue Severity Scale (FSS). [1]
The FSS-11 is commonly used to evaluate fatigue severity in chronic illness research.
The authors concluded:
“Ceftriaxone treatment may be the best choice for antibiotic treatment of PTLD.” [1]
The review suggested that IV ceftriaxone may provide measurable improvement for some patients with persistent fatigue symptoms after Lyme disease.
Short-Term Cognitive Improvement Was Also Reported
The meta-analysis also referenced an NIH-sponsored trial by Fallon and colleagues evaluating repeated IV ceftriaxone therapy for Lyme encephalopathy. [2]
That study demonstrated short-term cognitive improvement in some patients treated with intravenous ceftriaxone. [2]
However, benefits appeared limited over time, and the trials did not demonstrate consistent improvement across all outcome measures.
What Did Not Improve
The review did not find statistically significant improvement in several other measures, including:
- Beck Depression Inventory (BDI)
- Mental Health Scale scores
- Physical Functioning Scales
- Pain-related outcomes
Oral doxycycline also failed to demonstrate significant gains in the reviewed studies. [1]
Important Limitations of the Research
Zhang and colleagues acknowledged several limitations in the available evidence. [1]
- The total number of randomized trials was small.
- Treatment durations and antibiotic doses varied between studies.
- Follow-up periods differed substantially.
- The studies evaluated heterogeneous patient populations.
These limitations make it difficult to determine which patients may benefit most from IV therapy.
The Ongoing Debate Over PTLDS
One unresolved question remains whether persistent symptoms reflect:
- Residual inflammation after infection
- Immune dysregulation
- Persistent infection in some patients
- A combination of overlapping mechanisms
Reliable biomarkers capable of distinguishing these possibilities remain limited.
As a clinician, I remain cautious about assuming all persistent symptoms are entirely disconnected from ongoing infection.
Learn more about Post-Treatment Lyme Disease Syndrome, neurologic Lyme disease, and recovery from Lyme disease.
Frequently Asked Questions
Can IV antibiotics help PTLDS?
Some studies suggest IV ceftriaxone may improve fatigue and short-term cognitive symptoms in selected PTLDS patients.
Did oral doxycycline improve PTLDS symptoms?
The reviewed studies did not demonstrate significant improvement with oral doxycycline.
What symptoms improved with IV ceftriaxone?
Fatigue scores and some cognitive measures improved in certain studies.
Did IV antibiotics improve pain in PTLDS?
The reviewed trials did not show clear improvement in pain-related outcomes.
Why is PTLDS still controversial?
Researchers still lack reliable biomarkers capable of determining whether persistent symptoms reflect inflammation, immune dysfunction, persistent infection, or overlapping mechanisms.
Clinical Takeaway
A recent meta-analysis suggests that IV ceftriaxone may improve fatigue and short-term cognitive symptoms in selected PTLDS patients.
However, the evidence remains limited by small trial sizes, inconsistent study designs, and uncertainty surrounding the underlying cause of persistent symptoms.
More precise biomarkers and individualized treatment approaches are still needed to clarify which patients may benefit from IV therapy.
Related Articles
Podcast: Post-Treatment Lyme Disease Syndrome Cases
4 Distinct Post-Treatment Lyme Disease Syndromes?
Number of Post-Treatment Lyme Disease Syndrome Cases Expected to Soar
Lyme Disease Misdiagnosis
Lyme Disease Treatment
References
- Zhang X, Jiang Y, Chen Y, et al. Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis. BMC Infect Dis. 2023;23(1):22.
- Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
I was on i.v. picc line for LD treatment after participating in LD vaccine clinical trials 1995-1996. I nearly died if it weren’t for Sam Donta! Study trial docs were condescending and in denial of my symptoms. After 4 mos on i.v. ceftriaxone I was so.. much better As was my 10 year old son.. born with Bartonella & suffered for years. 5th grade was my son best year! To see the before & after i.v. therapy results of Spec scans (brain) was nothing short of amazing!! I def wouldn’t be here if not for this treatment. Im just sorry not enough influential people LISTENED 28 years ago!!
So sorry you had to go through this. And happy that your child is well. May I ask if he has sustained remission from bartonella? I did not know that ceftriaxone could hit bartonella.
Hi there and thanks much for your work. My question would concern the specific bacteria bartonella and the fact(?) that this microbe seems to only respond to the rif’s -rifampin and the other. Bartonella is such a prevalent (and very hard to eradicate) “co-infection” that it has been postulated it could be the “primary” infection.
Good afternoon Doctor.Hope all is fine. My IgG immunoblot test was positive for the next three antigens: Flagellin (p41), OspC (OspC), p83 (p83). IgM immunoblotting was borderline for: Flegellin Borrelia afzelii (p41), OspC Borrelia afzelii (OspC Ba); OspC Borrelia burgdorferi (OspC Bb), OSpC Borrelia garinii (OspC Bg). No any doctor said that it can be conisdered as Lyme 100% ,but also not declined a possibility. But i never seen a tick bite.
I was treated for 30 days by Doxy and joints pain has gone. However two month after i still have muscle twitching in the calves 24/7 non stop. And motor nerve involvement shown in EMG. Nerve conduction study has shown slight difference in signals but not critical.
Now i was suggested to make a second round of AB (after 2 month from previous treatment) ; Ceftriaxone 21d + oral Doxy. Does the Ceftriaxone injection to the muscles have same effect as IV ? Thank you.
I am not sure IM has the same benefit of IV. Moreover it is difficult to administer 2,000 mg of intravenous ceftriaxone as a IM treatment.